 | Up a level |
2014
Burmester, G., Rubbert-Roth, A., Cantagrel, A., Hall, S., Leszczynski, P., Feldman, D., Rangaraj, M. J., Roane, G., Ludivico, C., Mysler, E., Bennett, M. J., Rowell, L. and Bao, M. (2014). THE EFFICACY AND SAFETY OF SUBCUTANEOUS TOCILIZUMAB VERSUS INTRAVENOUS TOCILIZUMAB IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH RA AT WEEK 97 (SUMMACTA). Ann. Rheum. Dis., 73. S. 499 - 501. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060
Genovese, M., Sebba, A., Youssef, P., Rischmueller, M., Jones, G., Rubbert-Roth, A., Scali, J., Alten, R., Kremer, J., Pitts, L., Rowell, L. and Van Vollenhoven, R. (2014). LONG-TERM SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS FOLLOWING A MEAN TREATMENT DURATION OF 3.9 YEARS (ENCORE). Intern. Med. J., 44. S. 25 - 26. HOBOKEN: WILEY-BLACKWELL. ISSN 1445-5994